Essential Tremor
Neurology·MeSH: Tremor
Prevalence
4150.0 / 100K
Incidence
616.0 / 100K/yr
8 drugs in development·4 companies·9 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Phase 2(2)
Preclinical(1)
| Drug | Company |
|---|---|
| SAGE-817 | Sage Therapeutics, Inc. (SAGE) |
Phase 2/Phase 3(3)
Compare drugs
Frequently asked questions
How many drugs are in development for Essential Tremor?
BioSniper tracks 8 drugs in development for Essential Tremor across 4 companies.
How many clinical trials target Essential Tremor?
There are 9 clinical trials targeting Essential Tremor tracked by BioSniper.
What is the prevalence of Essential Tremor?
The estimated prevalence of Essential Tremor is approximately 4150.0 per 100,000 population.
Deep-dive into Essential Tremor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis